Trials / Unknown
UnknownNCT01998334
Continuous Blood Purification for Regulation of Early Inflammatory Response In Severe Acute Pancreatitis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Systemic Inflammatory response syndrome(SIRS) is common in patients with severe acute pancreatitis (SAP) in early stage. Continuous Blood Purification (CBP), especially Continuous Veno-Venous Hemofiltration(CVVH) is proved to have an important role in SAP patients to control SIRS. But the detail treatment for this is controversial. In this study, the investigators aim to evaluate the different effects of three kinds of treatment protocols which is CVVH 6h,continuous venovenous hemodiafiltration(CVVHDF) 6h,CVVH 10h for first three days in SAP patients. Compare the vital sign, SIRS parameters, and others between these three groups. This study will try to find a better way for CBP in patients with SAP
Detailed description
Condition Severe Acute Pancreatitis Intervention CVVH 6 hours for first three days CVVH 10 hours for first three days CVVHDF 6 hours for first three days All therapeutic volume is 45ml/kg.h, Device: Braxter HF 1200
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | CVVH 6h | CVVH 6h for first three days |
| OTHER | CVVH 10h | CVVH 10h for first three days |
| OTHER | CVVHDF 6h | CVVHDF 6h for first three days |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2015-12-01
- Completion
- 2016-12-01
- First posted
- 2013-11-28
- Last updated
- 2013-11-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01998334. Inclusion in this directory is not an endorsement.